MRFF - SCTM - 2025 Stem Cell Therapies Grant Opportunity

Overview

The Medical Research Future Fund (MRFF) Stem Cell Therapies Mission aims to support world-leading translational stem cell research that develops and delivers innovative, safe and effective stem cell medicines to improve health outcomes, in partnership with patients and carers. The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that:  Stream 1 (Priority area 1.3; Targeted Call for Research): conduct early stage clinical trials (Phase I/IIa) of new stem cell therapies, including: exploratory (pilot) studies to assist the design of clinical studies that will evaluate the safety and preliminary efficacy of novel stem cell–based treatments  clinical studies such as Phase I/IIa trials for novel stem cell–based treatments to demonstrate safety and/or initial efficacy.  Stream 2 (Priority area 3.1; Targeted Call for Research): conduct research that focuses on the following priority areas for the stem cell sector: appropriate ethical and regulatory frameworks ownership and use of cells and cellular products  community understanding and expectation in stem cell therapies, including approval processes  health economics assessments and evaluations.  The intended outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by:  Stream 1: generating evidence on the safety and efficacy of promising stem cell treatments.  Stream 2: building the evidence base to improve community trust, acceptance, and adoption of stem cell-based therapies.  This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health and Aged Care. Further information on the Medical Research Future Fund is available from the Department of Health and Aged Care’s website. A list of Eligible Organisations can be found on the NHMRC List of MRFF Eligible Organisations webpage.